98%
921
2 minutes
20
Objectives: This study aims to define consensus-based criteria for acquiring and reporting prostate MRI and establishing prerequisites for image quality.
Methods: A total of 44 leading urologists and urogenital radiologists who are experts in prostate cancer imaging from the European Society of Urogenital Radiology (ESUR) and EAU Section of Urologic Imaging (ESUI) participated in a Delphi consensus process. Panellists completed two rounds of questionnaires with 55 items under three headings: image quality assessment, interpretation and reporting, and radiologists' experience plus training centres. Of 55 questions, 31 were rated for agreement on a 9-point scale, and 24 were multiple-choice or open. For agreement items, there was consensus agreement with an agreement ≥ 70% (score 7-9) and disagreement of ≤ 15% of the panellists. For the other questions, a consensus was considered with ≥ 50% of votes.
Results: Twenty-four out of 31 of agreement items and 11/16 of other questions reached consensus. Agreement statements were (1) reporting of image quality should be performed and implemented into clinical practice; (2) for interpretation performance, radiologists should use self-performance tests with histopathology feedback, compare their interpretation with expert-reading and use external performance assessments; and (3) radiologists must attend theoretical and hands-on courses before interpreting prostate MRI. Limitations are that the results are expert opinions and not based on systematic reviews or meta-analyses. There was no consensus on outcomes statements of prostate MRI assessment as quality marker.
Conclusions: An ESUR and ESUI expert panel showed high agreement (74%) on issues improving prostate MRI quality. Checking and reporting of image quality are mandatory. Prostate radiologists should attend theoretical and hands-on courses, followed by supervised education, and must perform regular performance assessments.
Key Points: • Multi-parametric MRI in the diagnostic pathway of prostate cancer has a well-established upfront role in the recently updated European Association of Urology guideline and American Urological Association recommendations. • Suboptimal image acquisition and reporting at an individual level will result in clinicians losing confidence in the technique and returning to the (non-MRI) systematic biopsy pathway. Therefore, it is crucial to establish quality criteria for the acquisition and reporting of mpMRI. • To ensure high-quality prostate MRI, experts consider checking and reporting of image quality mandatory. Prostate radiologists must attend theoretical and hands-on courses, followed by supervised education, and must perform regular self- and external performance assessments.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476997 | PMC |
http://dx.doi.org/10.1007/s00330-020-06929-z | DOI Listing |
Eur J Nucl Med Mol Imaging
September 2025
Department of PET-CT/MRI, NHC Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Objective: CXCR4 and integrin αβ play important roles in tumor biology and are highly expressed in multiple types of tumors. This study aimed to synthesize, preclinically evaluate, and clinically validate a novel dual-targeted PET imaging probe Ga-pentixafor-c(RGDfK) for its potential in imaging tumors.
Methods: The effects of Ga-pentixafor-c(RGDfK) on cell viability, targeting specificity, and affinity were assessed in the U87MG cells.
Rep Pract Oncol Radiother
August 2025
Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Background: This study evaluates the quality of synthetic computed tomography (sCT) images for MR-only radiotherapy in prostate cancer using gamma analysis. A software tool, MRGamma, was developed to address challenges like the absence of electron density maps and registration uncertainties between magnetic resonance imaging (MRI) and planning CT (pCT).
Materials And Methods: Aplication developed in MATLAB assesses Hounsfield units (HU) discrepancies between CT and sCT images via 2D and 3D gamma analysis (GA).
Radiol Case Rep
November 2025
Department of Clinical and Experimental Medicine, Foggia University School of Medicine, Viale L. Pinto 1, 71122 Foggia, Italy.
We report a rare case of breast and axillary metastases in a 75-year-old man diagnosed with prostate carcinoma. Initially, the patient presented with lower urinary tract symptoms (LUTS) and elevated prostate-specific antigen (PSA) levels. Prostate cancer was confirmed by biopsy and treated with androgen deprivation therapy (ADT) and radiotherapy.
View Article and Find Full Text PDFUrol Case Rep
November 2025
Department of Translational Medicine, University of Eastern Piedmont, Maggiore della Carità University Hospital, 28100, Novara, Italy.
The aim of this study is to report a case of penile metastasis from prostate carcinoma, as it represents a very rare occurrence that clinicians should be aware of. We report a case of a 68-year-old patient affected by prostate cancer who has performed a PSMA-PET after radical prostatectomy for PSA elevation, which revealed a suspected uptake in the corpora cavernosa and corpora spongiosum, followed by multiparametric MRI examination with focus on penile involvement.
View Article and Find Full Text PDFInt J Med Robot
October 2025
School of Mechatronical Engineering, Beijing Institute of Technology, Beijing, China.
Background: The limited workspace and strong magnetic field inside MRI challenge the design of the prostate puncture robot. Simplifying the robot's structure is crucial.
Methods: This paper proposes a parallel cable-driven (PCD) prostate puncture robot, and conducts a preliminary material design.